NCT07529951 2026-04-14
Study of ZE74-0282 for Patients With JAK2 V617F Positive Blood Cancers
Eilean Therapeutics
Phase 1 Not yet recruiting
Eilean Therapeutics
University of Turin, Italy
Peking Union Medical College Hospital
Ono Pharmaceutical Co. Ltd
Brigham and Women's Hospital